Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 9,513 | 6,916 | 8,198 | 8,559 | 8,154 |
| Income taxes - deferred | -131 | -14 | -927 | -1,411 | -919 |
| Accounts receivable | 363 | 129 | 3,142 | -2,114 | -2,138 |
| Accounts payable and accrued liabilities | -2,068 | -979 | -7,804 | 10,781 | -969 |
| Other Working Capital | -581 | -619 | -7,615 | 1,150 | -3,612 |
| Other Operating Activity | -1,250 | -3,068 | 790 | -11,616 | 1,829 |
| Operating Cash Flow | $5,846 | $2,365 | $-4,216 | $5,349 | $2,345 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -5 | -1 | -26 | -60 |
| Purchase Sale Intangibles | -2,818 | -41,064 | -311 | -448 | 303 |
| Other Investing Activity | 0 | 8,400 | -1,825 | -6,575 | -5,325 |
| Investing Cash Flow | $-2,822 | $-32,669 | $-2,137 | $-7,049 | $-5,082 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,408 | -1,380 | -1,373 | -1,503 | -1,382 |
| Dividend Paid | -1,238 | -1,201 | -1,169 | -1,141 | -1,143 |
| Other Financing Activity | 0 | 19,525 | -152 | 1,604 | -54 |
| Financing Cash Flow | $-3,646 | $16,944 | $-2,694 | $-1,040 | $-2,579 |
| Exchange Rate Effect | 344 | 588 | 1,060 | -2,689 | 1,051 |
| Beginning Cash Position | 20,890 | 33,662 | 41,649 | 47,078 | 51,343 |
| End Cash Position | 20,612 | 20,890 | 33,662 | 41,649 | 47,078 |
| Net Cash Flow | $-622 | $-13,360 | $-9,047 | $-2,740 | $-5,316 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,846 | 2,365 | -4,216 | 5,349 | 2,345 |
| Capital Expenditure | -2,822 | -41,069 | -312 | -474 | N/A |
| Free Cash Flow | 3,024 | -38,704 | -4,528 | 4,875 | 2,345 |